Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
Study NCT ID:
NCT05394012
Status:
UNKNOWN
Last Update Posted:
2022-11-18
First Post:
2022-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
Sponsor:
Walvax Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-25
First Submit QC Date:
None
Study First Post Date:
2022-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-15
Last Update Post Date:
2022-11-18
Last Update Post Date Type:
ACTUAL